|
CA672478A
(en)
|
|
1963-10-15 |
Heim Roger |
Psilocybin and psilocin
|
|
LU36879A1
(https=)
|
1958-02-21 |
|
|
|
|
GB911946A
(en)
|
1958-02-21 |
1962-12-05 |
Sandoz Ltd |
Psilocybin and psilocin and processes for their preparation
|
|
US3075992A
(en)
|
1958-09-12 |
1963-01-29 |
Sandoz Ltd |
Esters of indoles
|
|
NL243249A
(https=)
|
1958-09-12 |
|
|
|
|
US3192111A
(en)
*
|
1959-02-16 |
1965-06-29 |
Sandoz Ltd |
Method of inducing therapeutic tranquilization with psilocybin and psilocin
|
|
IE24138L
(en)
|
1959-02-18 |
1959-08-21 |
Sandoz Ag |
Psilocybin and psilocin
|
|
JPS5576859A
(en)
|
1978-12-01 |
1980-06-10 |
Fujimoto Seiyaku Kk |
Novel preparation of 4-hydroxyindole
|
|
JPS5728046A
(en)
|
1980-07-28 |
1982-02-15 |
Nissan Chem Ind Ltd |
Preparation of 4-substituted indole
|
|
US4499096A
(en)
|
1983-11-18 |
1985-02-12 |
Lotsof Howard S |
Rapid method for interrupting the narcotic addiction syndrome
|
|
EP0152379A3
(de)
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
IL76591A0
(en)
|
1984-10-05 |
1986-02-28 |
Bioferon Biochem Substanz |
Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
|
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
US4587243A
(en)
|
1985-07-15 |
1986-05-06 |
Lotsof Howard S |
Rapid method for interrupting the cocaine and amphetamine abuse syndrome
|
|
IL80230A
(en)
|
1985-10-04 |
1993-03-15 |
South African Inventions |
Protein binding reagent
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
EP0493380B1
(en)
|
1989-09-05 |
1997-10-29 |
University Of Utah Research Institute |
Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US5935925A
(en)
|
1990-05-08 |
1999-08-10 |
Synaptic Pharmaceutical Corporation |
Methods of treating migraine and compounds useful for such methods
|
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
ES2193132T3
(es)
|
1990-10-19 |
2003-11-01 |
Univ New York |
Procedimiento para transplantar celulas en el cerebro y utilizaciones terapeuticas del mismo.
|
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
|
FR2675504B1
(fr)
|
1991-04-16 |
1995-01-27 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
|
|
US5468486A
(en)
|
1992-01-21 |
1995-11-21 |
The University Of Tennessee Research Corporation |
Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
|
|
US5482706A
(en)
|
1992-04-17 |
1996-01-09 |
Takeda Chemical Industries, Ltd. |
Transmucosal therapeutic composition
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
DK0628042T3
(da)
|
1992-12-24 |
2001-11-12 |
Pharmacia & Upjohn Spa |
Serotoninerge ergolinderivater
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US20060019963A1
(en)
|
1994-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Compounds
|
|
MX9701430A
(es)
|
1994-07-25 |
1997-12-31 |
Nda Int Inc |
Un metodo de tratamiento de dependencia quimica en mamiferos y una composicion para el mismo.
|
|
US5874477A
(en)
|
1994-08-12 |
1999-02-23 |
The University Of Hawaii |
Method of treatment for malaria utilizing serotonin receptor ligands
|
|
US5696125A
(en)
|
1995-02-24 |
1997-12-09 |
Research Foundation Of The State University Of New York |
Substance abuse-induced hemorrhagic stoke in an animal model
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
NZ311474A
(en)
|
1995-06-09 |
1997-09-22 |
Euro Celtique Sa |
Formulations for providing prolonged local anesthesia
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
DE19542281C2
(de)
|
1995-11-14 |
1997-12-04 |
Boehringer Ingelheim Kg |
Verwendung von Epinastin für die Behandlung der Migräne
|
|
FR2744361B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744363B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744362B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744364B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
WO1997035584A1
(en)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Method for treating pain
|
|
TW448171B
(en)
|
1996-06-06 |
2001-08-01 |
Yamanouchi Pharma Co Ltd |
Imidazole-substituted quinoxalinedione derivatives
|
|
WO1997047285A1
(en)
|
1996-06-10 |
1997-12-18 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5902815A
(en)
|
1996-09-03 |
1999-05-11 |
Washington University |
Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
|
|
US5958919A
(en)
|
1996-09-20 |
1999-09-28 |
Washington University |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
|
|
US5891885A
(en)
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US5804592A
(en)
|
1997-05-30 |
1998-09-08 |
Unimed Pharmaceuticals, Inc. |
Method for improving disturbed behavior and elevating mood in humans
|
|
EP1019041A4
(en)
|
1997-05-07 |
2002-04-17 |
Unimed Pharmaceutical Inc |
METHODS TO IMPROVE BEHAVIORAL BEHAVIOR AND RAISE MIND IN PEOPLE
|
|
US6558956B1
(en)
|
1997-06-24 |
2003-05-06 |
The University Of Wyoming |
Method and apparatus for detection of a controlled substance
|
|
GB9715082D0
(en)
|
1997-07-17 |
1997-09-24 |
Scherer Ltd R P |
Treatment of attention deficit hyperactivity disorder and narcolepsy
|
|
US7799337B2
(en)
|
1997-07-21 |
2010-09-21 |
Levin Bruce H |
Method for directed intranasal administration of a composition
|
|
US20010004644A1
(en)
|
1997-07-21 |
2001-06-21 |
Levin Bruce H. |
Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
|
|
WO1999009828A1
(en)
|
1997-08-25 |
1999-03-04 |
Pentech Pharmaceuticals, Inc. |
Method for amelioration of social phobia
|
|
EP1009407B1
(en)
|
1997-09-04 |
2004-04-28 |
Novoneuron, Inc. |
Noribogaine in the treatment of pain and drug addiction
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
DE19738855C2
(de)
|
1997-09-05 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
EP1027057A4
(en)
|
1997-10-28 |
2003-01-02 |
Vivus Inc |
TREATMENT OF FEMALE SEXUAL DISORDERS
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
|
ITTO980264A1
(it)
|
1998-03-26 |
1999-09-26 |
Silvio Rossi |
Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
|
|
AU4254799A
(en)
|
1998-06-22 |
2000-01-10 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
|
WO2000003679A2
(en)
|
1998-07-14 |
2000-01-27 |
Adams Food Ltd. |
Nutritionally active composition for hardening fingernails
|
|
WO2000003746A2
(en)
|
1998-07-14 |
2000-01-27 |
The Brigham And Women's Hospital, Inc. |
Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
JP2002520353A
(ja)
|
1998-07-16 |
2002-07-09 |
マサチューセッツ インスティテュート オブ テクノロジー |
ストレスの処置のための組成物
|
|
AU5243999A
(en)
|
1998-07-31 |
2000-02-21 |
Vela Pharmaceuticals Inc. |
Methods and compositions for treating and preventing substance abuse using moclobemide
|
|
CN1269484C
(zh)
|
1998-09-18 |
2006-08-16 |
艾尔科实验室公司 |
用于治疗青光眼的5－羟色胺激活性激动剂
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
US6962717B1
(en)
|
1999-01-29 |
2005-11-08 |
Disphar International B.V. |
Pharmaceutical compositions
|
|
CN100548290C
(zh)
|
1999-02-24 |
2009-10-14 |
辛辛那提大学 |
氨基磺酸酯衍生物用于治疗冲动控制障碍的用途
|
|
AU3760300A
(en)
|
1999-03-19 |
2000-10-09 |
Brigham And Women's Hospital |
Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
EP1165054A4
(en)
|
1999-04-06 |
2005-02-09 |
Pharmaquest Ltd |
PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT DELIVERY OF METHYLPHENIDATE
|
|
AP2001002290A0
(en)
|
1999-04-07 |
2001-12-31 |
Pfizer Prod Inc |
Use of CYP2D6 inhibitors in combination therapies.
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
US6126924A
(en)
|
1999-05-27 |
2000-10-03 |
Scales-Medeiros; Virginia A. |
Light responsive self-tanning products and methods for use
|
|
US6489341B1
(en)
|
1999-06-02 |
2002-12-03 |
Sepracor Inc. |
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
MXPA02001882A
(es)
|
1999-08-23 |
2002-08-20 |
Univ Tulane |
Modulacion del transportador de leptina a traves de la barrera hemato-encefalica.
|
|
US6204245B1
(en)
|
1999-09-17 |
2001-03-20 |
The Regents Of The University Of California |
Treatment of narcolepsy with immunosuppressants
|
|
WO2001026642A2
(en)
|
1999-10-08 |
2001-04-19 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
ES2162746B1
(es)
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
|
CA2400803A1
(en)
|
2000-01-18 |
2001-07-26 |
Richard A. Stone |
Ocular growth and nicotinic antagonists
|
|
US20030096831A1
(en)
|
2000-01-18 |
2003-05-22 |
Stone Richard A. |
Ocular growth and nicotinic antagonists
|
|
FR2804603B1
(fr)
|
2000-02-04 |
2004-01-23 |
Rhodia Chimie Sa |
Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
AU2001243369A1
(en)
|
2000-03-14 |
2001-09-24 |
Massachusetts Institute Of Technology |
Composition and method to treat weight gain and obesity attributable to psychotropic drugs
|
|
CA2404461A1
(en)
|
2000-03-27 |
2001-10-04 |
Pe Corporation (Ny) |
Human g-protein coupled receptors
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
US6380176B2
(en)
|
2000-03-28 |
2002-04-30 |
Ajinomoto Co., Inc. |
Method for inhibiting non-intentional behavior with a running neuron inhibitory substance
|
|
DE10018834A1
(de)
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
|
AU6106801A
(en)
|
2000-04-28 |
2001-11-12 |
Gary W. Neal |
Trans-clitoral administration of therapy
|
|
JP4763957B2
(ja)
|
2000-05-10 |
2011-08-31 |
オバン・エナジー・リミテッド |
メディアミリング
|
|
US20070059367A1
(en)
|
2000-06-06 |
2007-03-15 |
Cherukuri S R |
Drug Delivery System and Associated Methods
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
CA2416650C
(en)
|
2000-07-19 |
2010-09-21 |
Pitmy International N.V. |
Enhancement of the action of central and peripheral nervous system agents
|
|
AU2001291114A1
(en)
|
2000-09-19 |
2002-04-02 |
Microbia, Inc. |
Modulation of secondary metabolite production by zinc binuclear cluster proteins
|
|
US9474776B2
(en)
|
2000-10-04 |
2016-10-25 |
Paul Edward Stamets |
Integrative fungal solutions for protecting bees
|
|
US9399050B2
(en)
|
2000-10-04 |
2016-07-26 |
Paul Edward Stamets |
Controlling insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
|
|
US20070100000A1
(en)
|
2000-11-01 |
2007-05-03 |
Epstein Mel H |
Methods of providing neuroprotection
|
|
US20030119884A1
(en)
|
2000-11-01 |
2003-06-26 |
Epstein Mel H. |
Methods and compositions for regulating memory consolidation
|
|
AR031473A1
(es)
|
2000-11-20 |
2003-09-24 |
Lundbeck & Co As H |
Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
|
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
|
IL139975A0
(en)
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
BR0115783A
(pt)
|
2000-11-30 |
2003-09-16 |
Pfizer Prod Inc |
Combinação de agonistas de gaba e inibidores de sorbitol desidrogenase
|
|
EP1337272A2
(en)
|
2000-11-30 |
2003-08-27 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
|
US20020137785A1
(en)
|
2001-03-26 |
2002-09-26 |
George Kindness |
Inflammatory mechanism modulator composition and methods with anti-asthmatic properties
|
|
US20050096396A1
(en)
|
2002-03-28 |
2005-05-05 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
WO2002078643A2
(en)
|
2001-03-30 |
2002-10-10 |
Philadelphia Health And Education Corporation |
Immunomodulation and effect on cell processes relating to serotonin family receptors
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
AU2002303577B2
(en)
|
2001-05-04 |
2006-06-08 |
Merck & Co., Inc. |
Method and compositions for treating migraines
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
US20040023952A1
(en)
|
2001-06-20 |
2004-02-05 |
Leventhal Audie G. |
Enhanced brain function by gaba-ergic stimulation
|
|
WO2003016903A2
(de)
|
2001-08-20 |
2003-02-27 |
Walter Pils |
Vorrichtung und verfahren zum nachweis eines analyten
|
|
US6541043B2
(en)
|
2001-08-28 |
2003-04-01 |
Dexgen Pharmaceuticals, Inc. |
Method and synergistic composition for treating attention deficit/hyperactivity disorder
|
|
US20030099711A1
(en)
|
2001-08-29 |
2003-05-29 |
David Meadows |
Sustained release preparations
|
|
AU2002339224B2
(en)
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
JP4360906B2
(ja)
|
2001-09-14 |
2009-11-11 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子によって誘導される免疫応答を高めるための、抗原提示細胞のインビボでの活性化
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
WO2003026564A2
(en)
|
2001-09-27 |
2003-04-03 |
Pharmacia Ab |
Pharmaceutical compositions for the treatment of urinary disorders
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
US20060264508A1
(en)
|
2001-10-16 |
2006-11-23 |
Stone Richard A |
Modulation of ocular growth and myopia by gaba drugs
|
|
US20030082225A1
(en)
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
WO2003041645A2
(en)
|
2001-11-09 |
2003-05-22 |
Chiron Corporation |
Method of vaccinating a human patient to prevent metastatic tumors
|
|
GB0127832D0
(en)
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
|
AU2002352868A1
(en)
|
2001-11-27 |
2003-06-10 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
CA2468015A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
2-aminoquinoline compounds
|
|
AU2002219964A1
(en)
|
2001-11-29 |
2003-06-17 |
Penwest Pharmaceutical Company |
Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
|
|
US7241797B2
(en)
|
2002-01-23 |
2007-07-10 |
University Of Cincinnati |
Method of increasing milk production
|
|
US20030171435A1
(en)
|
2002-01-23 |
2003-09-11 |
Drug Abuse Sciences, Inc. |
New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
|
|
EP1480624B1
(en)
|
2002-02-07 |
2006-11-29 |
Pharmacia Corporation |
Pharmaceutical tablet
|
|
PL372290A1
(en)
|
2002-02-07 |
2005-07-11 |
Pharmacia Corporation |
Pharmaceutical dosage form for mucosal delivery
|
|
US20030153552A1
(en)
|
2002-02-14 |
2003-08-14 |
Mash Deborah C. |
Method of treating chemical dependency in mammals and a composition therefor
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
|
US20030199439A1
(en)
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
|
US20030232805A1
(en)
|
2002-04-24 |
2003-12-18 |
Cypress Bioscience, Inc. |
Prevention and treatment of functional somatic disorders, including stress-related disorders
|
|
US20060034872A1
(en)
|
2002-04-29 |
2006-02-16 |
Woolf Clifford J |
Compositions and methods for preventing abuse of orally administered medications
|
|
AUPS317102A0
(en)
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
|
WO2004003145A2
(en)
|
2002-06-28 |
2004-01-08 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
|
|
US20040006043A1
(en)
|
2002-07-02 |
2004-01-08 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
|
|
US10738268B2
(en)
|
2016-08-21 |
2020-08-11 |
Insectergy, Llc |
Cannabis nanoemulsion methods
|
|
US20050148673A1
(en)
|
2002-07-11 |
2005-07-07 |
Harbut Ronald E. |
Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
|
|
EP2351770A1
(en)
|
2002-07-17 |
2011-08-03 |
Cytos Biotechnology AG |
Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
JPWO2004014429A1
(ja)
|
2002-08-09 |
2005-12-02 |
三菱ウェルファーマ株式会社 |
精神疾患発症脆弱性制御剤
|
|
US20030114512A1
(en)
|
2002-09-09 |
2003-06-19 |
Collier Robert J |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
AU2003278832A1
(en)
|
2002-09-13 |
2004-04-30 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
|
WO2004026290A1
(en)
|
2002-09-19 |
2004-04-01 |
Merck & Co., Inc. |
Method for treating depression and/or anxiety
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
DE10244504A1
(de)
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
|
AU2003273977B2
(en)
|
2002-10-11 |
2007-07-12 |
Idea Ag |
Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
|
AU2003304211A1
(en)
|
2002-10-30 |
2005-01-04 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
|
|
DE10250944B9
(de)
|
2002-10-31 |
2004-09-16 |
Cell Center Cologne Gmbh |
Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
EP1585520A1
(en)
|
2002-12-24 |
2005-10-19 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
DK2009000T3
(da)
|
2003-01-16 |
2011-09-05 |
Acadia Pharm Inc |
Selektive serotonin 2A/2C-receptor invers-agonister som terapeutika for neurodegenerative sygdomme
|
|
CN1741803A
(zh)
|
2003-01-23 |
2006-03-01 |
阿卡蒂亚药品公司 |
N－脱甲基氯氮平在治疗人神经精神疾病中的用途
|
|
US20040186155A1
(en)
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
|
WO2004071431A2
(en)
|
2003-02-05 |
2004-08-26 |
Myriad Genetics, Inc. |
Method and composition for treating neurodegenerative disorders
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
CA2519117C
(en)
|
2003-03-17 |
2010-03-02 |
Neurohealing Pharmaceuticals, Inc. |
High potency dopaminergic treatment of neurological impairment associated with brain injury
|
|
EP1605972A2
(en)
|
2003-03-26 |
2005-12-21 |
Cytos Biotechnology AG |
Hiv-peptide-carrier-conjugates
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
MXPA05012850A
(es)
|
2003-05-29 |
2006-05-17 |
New River Pharmaceuticals Inc |
Compuestos de anfetamina resistentes al abuso.
|
|
JP2006526652A
(ja)
|
2003-06-03 |
2006-11-24 |
ベス・イスラエル・ディーコニス・メディカル・センター |
血管狭窄を治療するための方法及び化合物
|
|
US20070065463A1
(en)
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
|
JP4174016B2
(ja)
|
2003-07-11 |
2008-10-29 |
株式会社ビーエル |
競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット
|
|
US7276608B2
(en)
|
2003-07-11 |
2007-10-02 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US20050203011A1
(en)
|
2003-09-19 |
2005-09-15 |
The Regents Of The University Of California |
Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
|
|
US20050070501A1
(en)
|
2003-09-29 |
2005-03-31 |
New York Blood Center, Inc. |
Water dispersible film
|
|
JP4641942B2
(ja)
|
2003-10-03 |
2011-03-02 |
フェーイレン・ナムローゼ・フェンノートシャップ |
ヒトおよび動物におけるｉｇｆ−１血清レベルの低下と関連した種々の疾患状態の治療用の治療用組成物の製造のための血清中ｉｇｆ−１レベルを増加できる化合物の使用
|
|
WO2005037199A2
(en)
|
2003-10-10 |
2005-04-28 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
US20070053954A1
(en)
|
2003-10-24 |
2007-03-08 |
Rowe Stephen C |
Macromer-melt formulations
|
|
WO2005039502A2
(en)
|
2003-10-24 |
2005-05-06 |
Azopax Therapeutics Llc |
Macromer-melt formulations
|
|
JP2005132747A
(ja)
|
2003-10-29 |
2005-05-26 |
Ajinomoto Co Inc |
老齢伴侶動物の老化行動改善剤
|
|
EP1701725B1
(en)
|
2003-12-16 |
2013-07-31 |
Relevare Aust. Pty Ltd |
Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain
|
|
US20050260258A1
(en)
|
2003-12-18 |
2005-11-24 |
The Texas A&M University System |
Use of vitelline protein B as a microencapsulating additive
|
|
WO2005063248A1
(en)
|
2003-12-22 |
2005-07-14 |
Sepracor Inc. |
Modafinil combination therapy for improving sleep quality
|
|
WO2005063296A2
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Products Inc. |
Therapeutic combination for cognition enhancement and psychotic disorders
|
|
GB0400802D0
(en)
|
2004-01-14 |
2004-02-18 |
Daniolabs Ltd |
Compounds for the treatment of disease
|
|
WO2005072705A1
(en)
|
2004-01-29 |
2005-08-11 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
|
|
EP1734920A2
(en)
|
2004-02-13 |
2006-12-27 |
Neuromolecular Inc. |
Combination of a nmda receptor antagonist and an mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
|
|
CA2556214A1
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
US7981441B2
(en)
|
2004-02-18 |
2011-07-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Drug delivery systems using mesoporous oxide films
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
FR2867075B1
(fr)
|
2004-03-03 |
2006-07-14 |
Ethypharm Sa |
Procede de preparation de microspheres biodegradables calibrees
|
|
EP1729759A4
(en)
|
2004-03-12 |
2008-04-02 |
Mclean Hospital Corp |
SALVINORINE DERIVATIVES AND ITS USES
|
|
US20060270592A1
(en)
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
|
WO2005102366A2
(en)
|
2004-04-19 |
2005-11-03 |
Philip Maxwell Satow |
Lithium combinations, and uses related thereto
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
RU2253461C1
(ru)
|
2004-04-30 |
2005-06-10 |
Общество с ограниченной ответственностью "Паркинфарм" |
Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
|
|
US20050255091A1
(en)
|
2004-05-14 |
2005-11-17 |
Loomis Gary L |
Hydrogels for biomedical applications
|
|
US20050261278A1
(en)
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050265955A1
(en)
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
NL1026634C2
(nl)
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
|
US7799802B2
(en)
|
2004-08-03 |
2010-09-21 |
Institstute of Oriental Medical Science Inc. |
Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
|
|
US20060030625A1
(en)
|
2004-08-06 |
2006-02-09 |
Cheryle Ram Hart |
Dietary neurotransmitter precursors for balanced synthesis of neurotransmitters
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
SG155257A1
(en)
|
2004-09-24 |
2009-09-30 |
Beth Israel Hospital |
Methods of diagnosing and treating complications of pregnancy
|
|
AU2005300045A1
(en)
|
2004-09-27 |
2006-05-04 |
Organix, Inc. |
Indole compounds useful as serotonin selective agents
|
|
US20060240043A1
(en)
|
2004-10-08 |
2006-10-26 |
Meyerson Laurence R |
Methods and compositions for treating migraine pain
|
|
WO2006053383A1
(en)
|
2004-11-22 |
2006-05-26 |
Anadis Ltd |
Bioactive compositions
|
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
US7294649B2
(en)
|
2004-12-17 |
2007-11-13 |
Roche Diagnostics Operatins, Inc. |
Methamphetamine derivatives and conjugates for immunoassay
|
|
KR20070087678A
(ko)
|
2004-12-20 |
2007-08-28 |
컬리지움 파마슈티칼, 인코포레이티드 |
수면 장애용 약제 조성물
|
|
PL1844189T3
(pl)
|
2005-01-10 |
2021-10-25 |
Smiths Detection Inc. |
Sposób przygotowania wymazówki
|
|
DE102005004343A1
(de)
|
2005-01-25 |
2006-08-10 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Behandlung von Phantomphänomenen
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
MX2007011250A
(es)
|
2005-03-21 |
2007-11-14 |
Ivax Pharmaceuticals Sro |
Inhibidor de la cristalizacion y su uso en capsulas de gelatina.
|
|
PL1861427T3
(pl)
|
2005-03-23 |
2013-01-31 |
Bpsi Holdings Llc |
Kompozycje aglomerowanej skrobi
|
|
JP2008534562A
(ja)
|
2005-03-28 |
2008-08-28 |
オレクソ・アクチエボラゲット |
偏頭痛の治療に有用な新しい製薬組成物
|
|
US20060229293A1
(en)
|
2005-04-06 |
2006-10-12 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C
|
|
EP1865980A4
(en)
|
2005-04-08 |
2009-11-11 |
Shire Llc |
ABUSEFUL AMPHETAMINE PRODRUGS
|
|
JP2008537961A
(ja)
|
2005-04-15 |
2008-10-02 |
ボード、オブ、トラスティーズ、オブ、ミシガン、ステイト、ユニバーシティ |
Ｇｐｃｒモジュレーター
|
|
EP1868664A2
(en)
|
2005-04-15 |
2007-12-26 |
Interface Biologics Inc. |
Methods and compositions for the delivery of biologically active agents
|
|
AU2006239930A1
(en)
|
2005-04-22 |
2006-11-02 |
Wyeth |
Benzodioxane and benzodioxolane derivatives and uses thereof
|
|
JP4899012B2
(ja)
|
2005-05-06 |
2012-03-21 |
スミス・ディテクション・インコーポレイテッド |
パーオキシドベースの爆発物の改良された化学的検出
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
|
JP5284779B2
(ja)
|
2005-06-07 |
2013-09-11 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
コンジュゲート化された向精神薬の新規な塩およびその調製方法
|
|
EP2371394A1
(en)
|
2005-06-16 |
2011-10-05 |
Mohammed Saeed |
Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
|
|
US7645802B2
(en)
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
US9198862B2
(en)
|
2005-07-22 |
2015-12-01 |
Rubicon Research Private Limited |
Dispersible tablet composition
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
|
DE102005055866A1
(de)
|
2005-11-23 |
2007-05-24 |
Hte Ag The High Throughput Experimentation Company |
Verfahren zur Herstellung von Aryl-Aryl gekoppelter Verbindungen
|
|
EP1991207A2
(en)
|
2006-01-21 |
2008-11-19 |
Abbott GmbH & Co. KG |
Dosage form and method for the delivery of drugs of abuse
|
|
JP2009525124A
(ja)
|
2006-02-02 |
2009-07-09 |
メドロジックス・ディバイス・コーポレーション |
ゾル−ゲル組成物を含む生物活性材料送達系
|
|
US20070203216A1
(en)
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
US20070190130A1
(en)
|
2006-02-16 |
2007-08-16 |
Mark William A |
Protein hydrolysate excipients
|
|
US20080075789A1
(en)
|
2006-02-28 |
2008-03-27 |
The Regents Of The University Of California |
Genes differentially expressed in bipolar disorder and/or schizophrenia
|
|
WO2007103687A2
(en)
|
2006-03-01 |
2007-09-13 |
Tristrata, Inc. |
Composition and method for topical treatment of tar-responsive dermatological disorders
|
|
FR2898271B1
(fr)
|
2006-03-09 |
2009-01-16 |
Pierre Fabre Medicament Sa |
Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
|
|
WO2007111880A2
(en)
|
2006-03-22 |
2007-10-04 |
Mount Sinai School Of Medicine |
Intranasal administration of ketamine to treat depression
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
EP2010584A4
(en)
|
2006-04-14 |
2010-07-21 |
Interface Biologics Inc |
DIPPLETED POLYMERS AND APPLICATIONS THEREOF
|
|
GB0608647D0
(en)
|
2006-05-02 |
2006-06-14 |
Haritou Susan J A |
Methods of diagnosis and treatment
|
|
JP5052602B2
(ja)
|
2006-05-12 |
2012-10-17 |
シャイア エルエルシー |
制御用量薬物送達システム
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
ES2383768T3
(es)
|
2006-06-28 |
2012-06-26 |
Chelsea Therapeutics Inc. |
Composiciones farmacéuticas que comprenden droxidopa
|
|
CA2656112A1
(en)
|
2006-06-30 |
2008-05-08 |
Hanje Chen |
Bioresponsive polymers
|
|
EP2051735B1
(en)
|
2006-07-17 |
2012-08-29 |
Ramot, at Tel Aviv University Ltd. |
Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
|
|
CA2692440A1
(en)
|
2006-07-20 |
2008-01-24 |
Cascade Therapeutics Inc. |
Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
|
|
US20080026189A1
(en)
|
2006-07-27 |
2008-01-31 |
Chun-Wei Lin |
Thin key structure for generating dazzling light
|
|
MX2009001966A
(es)
|
2006-08-23 |
2009-06-19 |
Univ Montana |
Metodo de reduccion del daño celular neuronal.
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008026046A1
(en)
|
2006-08-30 |
2008-03-06 |
Pfizer Products Inc. |
Morpholine d3 dopamine antagonists
|
|
EP2081429A4
(en)
|
2006-08-31 |
2010-01-06 |
Biogen Idec Inc |
PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES
|
|
AU2007299920A1
(en)
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
CA2664935A1
(en)
|
2006-09-26 |
2008-04-03 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
|
|
WO2008038291A1
(en)
|
2006-09-27 |
2008-04-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy
|
|
DE602007010818D1
(de)
|
2006-10-27 |
2011-01-05 |
Janssen Pharmaceutica Nv |
Verfahren zur behandlung disruptiver verhaltensstörungen
|
|
AU2007309390A1
(en)
|
2006-10-27 |
2008-05-02 |
Medivation Neurology, Inc. |
Methods and combination therapies for treating Alzheimer's disease
|
|
BRPI0718323A2
(pt)
|
2006-10-31 |
2013-11-26 |
Janssen Pharmaceutica Nv |
Tratamento de transtornos invasivos do desenvolvimento.
|
|
US7718649B1
(en)
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
|
US8653106B2
(en)
|
2010-07-30 |
2014-02-18 |
Pisgah Laboratories, Inc. |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
|
|
US20080293695A1
(en)
|
2007-05-22 |
2008-11-27 |
David William Bristol |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
|
|
US9823737B2
(en)
*
|
2008-04-07 |
2017-11-21 |
Mohammad A Mazed |
Augmented reality personal assistant apparatus
|
|
US10529003B2
(en)
*
|
2008-04-07 |
2020-01-07 |
Mohammad A. Mazed |
Optical biomodule for detection of diseases at an early onset
|
|
ES2364865T3
(es)
|
2006-12-11 |
2011-09-15 |
Kempharm, Inc. |
Conjugados de ornitina de la anfetamina y procedimientos de fabricación y de utilización de los mismos.
|
|
ES2302650B1
(es)
|
2007-01-11 |
2009-02-16 |
Tedec-Meiji Farma, S.A. |
Composicion de rapida desintegracion en la cavidad bucal.
|
|
CA2677205A1
(en)
|
2007-01-31 |
2008-08-07 |
University Of Virginia Patent Foundation |
Topiramate plus naltrexone for the treatment of addictive disorders
|
|
EP2433655A3
(en)
|
2007-02-08 |
2013-05-15 |
Kempharm, Inc. |
Homoarginine-prodrugs of amphetamine
|
|
CN101657193A
(zh)
|
2007-03-09 |
2010-02-24 |
切尔西治疗公司 |
用于治疗纤维肌痛的屈昔多巴及其药物组合物
|
|
WO2008112773A2
(en)
|
2007-03-12 |
2008-09-18 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
|
|
US20080226715A1
(en)
|
2007-03-16 |
2008-09-18 |
Albert Cha |
Therapeutic compositions and methods
|
|
DE102007014286A1
(de)
|
2007-03-19 |
2008-09-25 |
Universität Tübingen |
Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
|
|
CN104906669A
(zh)
|
2007-03-30 |
2015-09-16 |
菲利普莫里斯生产公司 |
用于输送药剂的装置和方法
|
|
AT505086B1
(de)
|
2007-04-02 |
2009-06-15 |
Planta Naturstoffe Vertriebsge |
Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
|
|
WO2008122990A1
(en)
|
2007-04-04 |
2008-10-16 |
Almet Corporation Limited |
Compacting upflow extractor and method of using it
|
|
US8747832B2
(en)
|
2007-04-12 |
2014-06-10 |
Rutgers, The State University Of New Jersey |
Biodegradable polyanhydrides with natural bioactive molecules
|
|
US7687660B2
(en)
|
2007-04-18 |
2010-03-30 |
Teva Pharmaceutical Industries Ltd. |
Process for preparing intermediates of HMG-CoA reductase inhibitors
|
|
CN101765582A
(zh)
|
2007-04-26 |
2010-06-30 |
奥斯拜客斯制药有限公司 |
氘标记的氯胺酮
|
|
US10183001B1
(en)
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
|
US9421266B2
(en)
|
2007-05-22 |
2016-08-23 |
Pisgah Laboratories, Inc. |
Safety of pseudoephedrine drug products
|
|
EP2182957A4
(en)
|
2007-07-31 |
2012-07-18 |
Limerick Biopharma Inc |
PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS
|
|
CN101815519B
(zh)
|
2007-08-03 |
2013-08-21 |
吉瑞工厂 |
包含多巴胺受体配体的药物组合物和使用多巴胺受体配体的治疗方法
|
|
AU2016208412A1
(en)
|
2007-08-06 |
2016-08-18 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
MX2010001390A
(es)
|
2007-08-06 |
2010-08-02 |
Synosia Therapeutics Inc |
Métodos para el tratamiento de dependencia.
|
|
FR2919861A1
(fr)
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
|
US8222254B2
(en)
|
2007-08-07 |
2012-07-17 |
Prosarix Limited |
1, 2, 4-triazole derivatives as serotonergic modulators
|
|
US8067028B2
(en)
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
CA2701186C
(en)
|
2007-10-05 |
2017-09-19 |
Evonik Canada Inc. |
Oligofluorinated cross-linked polymers and uses thereof
|
|
US20110053859A1
(en)
|
2007-10-10 |
2011-03-03 |
The U. S. Government Respresented by the Department of Veterans Affairs |
Methods to reduce the effects of sleep deprivation
|
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
|
WO2009061436A1
(en)
|
2007-11-06 |
2009-05-14 |
University Of Florida Research Foundation |
Compound for activating 5-ht2c receptors in combination with an amphetamine compound
|
|
DE102007063210A1
(de)
|
2007-12-20 |
2009-06-25 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Arzneimittel zur Behandlung von Phantomphänomenen
|
|
WO2009079765A1
(en)
|
2007-12-21 |
2009-07-02 |
Cascade Therapeutics Inc. |
Compounds with activity at the 5-ht2c receptor
|
|
WO2009089234A2
(en)
|
2008-01-07 |
2009-07-16 |
Auspex Pharmaceuticals |
Substituted dibenzhydrylpiperazines
|
|
ES2620672T3
(es)
|
2008-01-09 |
2017-06-29 |
Charleston Laboratories, Inc. |
Comprimidos de doble capa que comprenden oxicodona y prometazina
|
|
US8137690B2
(en)
|
2008-01-17 |
2012-03-20 |
Health Innovations, Llc |
Taste titration therapies
|
|
AU2016203452B2
(en)
*
|
2008-01-22 |
2018-02-22 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
WO2009094172A2
(en)
*
|
2008-01-22 |
2009-07-30 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
AU2014203195B2
(en)
*
|
2008-01-22 |
2016-03-31 |
Araim Pharmaceuticals, Inc. |
Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
|
|
WO2009097596A1
(en)
|
2008-01-31 |
2009-08-06 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
US8329663B2
(en)
|
2008-01-31 |
2012-12-11 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
MX2010008024A
(es)
|
2008-02-01 |
2010-12-21 |
Ascendis Pharma As |
Profarmaco que comprende un enlazador que se puede separar por si mismo.
|
|
RU2540871C2
(ru)
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
EP2254865A1
(en)
|
2008-02-11 |
2010-12-01 |
Organix, Inc. |
Indole compounds and methods of use thereof
|
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
|
EA201001521A1
(ru)
|
2008-03-26 |
2011-04-29 |
Лонца Лтд. |
Способ синтеза этинилциклопропана
|
|
US20170276676A1
(en)
|
2008-03-27 |
2017-09-28 |
Gus J. Slotman |
System for assessing drug efficacy and response of a patient to therapy
|
|
WO2009118763A1
(en)
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Multilayered pharmaceutical compositions and processes thereof
|
|
US20090252786A1
(en)
|
2008-03-31 |
2009-10-08 |
Christoph Hanz |
Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
|
|
EP2106799A1
(en)
|
2008-03-31 |
2009-10-07 |
OWEN Holding LTD |
Use of a biologically active blood serum for the treatment of a disorder characterized in a reduced function of a GABA receptor
|
|
FR2930147B1
(fr)
|
2008-04-18 |
2013-02-08 |
Flamel Tech Sa |
Forme orale solide dotee d'un double profil de liberation
|
|
AU2009241847B2
(en)
|
2008-04-28 |
2014-07-10 |
Zogenix, Inc. |
Novel formulations for treatment of migraine
|
|
US20110086063A1
(en)
|
2008-06-04 |
2011-04-14 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US10388179B2
(en)
|
2008-06-18 |
2019-08-20 |
Accenture Global Solutions Limited |
Analytics platform
|
|
EP2285362B1
(en)
|
2008-06-19 |
2017-08-09 |
LTS LOHMANN Therapie-Systeme AG |
Composition for transdermal delivery of cationic active agents
|
|
WO2010001391A1
(en)
|
2008-06-30 |
2010-01-07 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
US9642819B2
(en)
|
2008-07-10 |
2017-05-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical |
Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
|
|
US8617607B2
(en)
|
2008-07-10 |
2013-12-31 |
Tyrx, Inc. |
Sustained release formulations of psychoactive drugs
|
|
EP2331088A4
(en)
|
2008-08-06 |
2011-10-12 |
Gosforth Ct Holdings Pty Ltd |
COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC ILLNESSES
|
|
FR2935611B1
(fr)
|
2008-09-10 |
2010-10-15 |
Commissariat Energie Atomique |
Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes
|
|
FR2936710B1
(fr)
|
2008-10-07 |
2011-01-07 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
CN102292094B
(zh)
|
2009-01-20 |
2013-08-14 |
洛杉矶生物医学研究所在哈伯-加州大学洛杉矶分校医疗中心 |
增强神经药方疗效的山梨酸与苯甲酸及其衍生物
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2010124089A2
(en)
|
2009-04-22 |
2010-10-28 |
Synosia Therapeutics, Inc. |
Methods for treating dependence
|
|
US20120159656A1
(en)
|
2009-04-24 |
2012-06-21 |
Galenea Corp. |
Compositions and methods for evaluating cognitive defects
|
|
WO2010136803A1
(en)
|
2009-05-26 |
2010-12-02 |
Shire Llc |
Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US20110306596A1
(en)
|
2009-07-27 |
2011-12-15 |
Auspex Pharmaceuticals, Inc. |
Benzazepine inhibitors of gamma-secretase
|
|
WO2011097269A1
(en)
|
2010-02-06 |
2011-08-11 |
Thar Pharmaceuticals, Inc. |
Crystallization method and bioavailability
|
|
US20120302590A1
(en)
|
2009-08-13 |
2012-11-29 |
The General Hospital Corporation |
Methods and compositions to prevent addiction
|
|
US20110038915A1
(en)
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
WO2011028875A1
(en)
|
2009-09-03 |
2011-03-10 |
Wake Forest University Health Sciences |
Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
|
|
WO2011027060A2
(fr)
|
2009-09-04 |
2011-03-10 |
Centre National De La Recherche Scientifique - Crns - |
Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
CA2774036C
(en)
|
2009-10-16 |
2018-04-03 |
Dsm Ip Assets B.V. |
Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
|
|
US20120321706A1
(en)
|
2009-10-19 |
2012-12-20 |
Intec Pharma Ltd. |
Novel gastroretentive dosage forms of poorly soluble drugs
|
|
WO2011072398A1
(en)
|
2009-12-18 |
2011-06-23 |
Interface Biologics, Inc. |
Local delivery of drugs from self assembled coatings
|
|
CA2829180C
(en)
|
2010-03-05 |
2019-01-15 |
Newagriculture, Inc. |
Leaf protein-lipid-soluble material complexes
|
|
US20110217289A1
(en)
|
2010-03-05 |
2011-09-08 |
Basf Se |
Melt-Coated Dosage Forms
|
|
ES2887335T3
(es)
|
2010-03-17 |
2021-12-22 |
Univ Cornell |
Vacuna contra las drogas de abuso basada en adenovirus alterado
|
|
WO2011138142A1
(en)
|
2010-05-07 |
2011-11-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Compositions and use of sulfasalazine
|
|
CA2797158A1
(en)
|
2010-05-10 |
2011-11-17 |
Segetis, Inc. |
Alkyl ketal esters as dispersants and slip agents for particulate solids, methods of manufacture, and uses thereof
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US20120108510A1
(en)
|
2010-05-20 |
2012-05-03 |
Emory University |
Methods of improving behavioral therapies
|
|
JP2012020991A
(ja)
|
2010-06-16 |
2012-02-02 |
Takasago Internatl Corp |
経皮吸収促進剤、及びこれを含有する皮膚外用製剤
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
EP2595632A1
(en)
|
2010-07-23 |
2013-05-29 |
DemeRx, Inc. |
Noribogaine compositions
|
|
US20120039999A1
(en)
|
2010-08-11 |
2012-02-16 |
Ashish Chatterji |
Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
|
|
WO2012022928A2
(en)
|
2010-08-20 |
2012-02-23 |
Heptares Therapeutic Ltd |
Biological materials and uses thereof
|
|
CN103221070B
(zh)
|
2010-08-30 |
2019-07-12 |
哈佛大学校长及研究员协会 |
用于狭窄病变和溶解血栓疗法的切变控制释放
|
|
US20130310422A1
(en)
|
2010-09-01 |
2013-11-21 |
The General Hospital Corporation |
Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
|
|
US20120129834A1
(en)
|
2010-09-17 |
2012-05-24 |
Buck Institute For Research On Aging |
Serotonin receptor antagonists for use in the treatment of huntington's disease
|
|
DK2618826T3
(en)
|
2010-09-20 |
2016-08-01 |
A Carlsson Res Ab |
Phenylpiperdine FOR TREATMENT OF DEMENTIA
|
|
AU2011313814B2
(en)
|
2010-10-07 |
2015-12-24 |
Eaglepharma Pty Ltd |
Combination therapy for the treatment of depression and other non-infectious diseases
|
|
EP2629615B1
(en)
|
2010-10-22 |
2018-10-10 |
Duke University |
Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
EP2640370B1
(en)
|
2010-11-15 |
2018-03-14 |
Neuroderm Ltd |
Compositions for transdermal delivery of active agents
|
|
EP2649443A2
(en)
|
2010-12-06 |
2013-10-16 |
Ramot at Tel-Aviv University Ltd |
Methods and kits for detection of drugs
|
|
IL298116A
(en)
|
2010-12-22 |
2023-01-01 |
Syqe Medical Ltd |
Method and system for drug delivery
|
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
FR2971423B1
(fr)
|
2011-02-15 |
2014-01-10 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
US8742096B2
(en)
|
2011-03-28 |
2014-06-03 |
Demerx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
CN103502817B
(zh)
|
2011-03-28 |
2016-01-20 |
前视红外系统股份有限公司 |
包括药物的分析物的检测方法
|
|
JOP20120083B1
(ar)
|
2011-04-05 |
2021-08-17 |
Otsuka Pharma Co Ltd |
توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
|
|
US20120282255A1
(en)
|
2011-04-07 |
2012-11-08 |
Greg Plucinski |
Methods and compositions for the treatment of alcoholism and alcohol dependence
|
|
KR20120128440A
(ko)
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
WO2012158892A2
(en)
|
2011-05-19 |
2012-11-22 |
Bruce Roseman |
A method of treating apraxia of speech in children
|
|
MX2013015373A
(es)
|
2011-06-23 |
2014-02-11 |
Map Pharmaceuticals Inc |
Nuevos analogos de fluoroergolina.
|
|
WO2013040471A2
(en)
|
2011-09-15 |
2013-03-21 |
Demerx, Inc. |
Noribogaine salt ansolvates
|
|
US20130116215A1
(en)
|
2011-10-28 |
2013-05-09 |
Mireia Coma |
Combination therapies for treating neurological disorders
|
|
EP2776069A1
(en)
|
2011-11-07 |
2014-09-17 |
Novartis AG |
Carrier molecule comprising a spr0096 and a spr2021 antigen
|
|
FR2983409B1
(fr)
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
|
CA3122767C
(en)
|
2011-12-08 |
2023-03-28 |
Demerx, Inc. |
Stereoselective total synthesis of noribogaine
|
|
CA2855994A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
JP2015509075A
(ja)
|
2011-12-09 |
2015-03-26 |
デメレックス， インコーポレイテッド |
ノルイボガインの硫酸エステル
|
|
EP2607352A1
(en)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-diketoamides for treatment of psychiatric disorders
|
|
EP2610245A1
(en)
|
2011-12-28 |
2013-07-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolate-sulfonamides for treatment of psychiatric disorders
|
|
US8877921B2
(en)
|
2012-01-25 |
2014-11-04 |
Demerx, Inc. |
Synthetic voacangine
|
|
EP2807167A4
(en)
|
2012-01-25 |
2016-01-20 |
Demerx Inc |
INDOIND AND BENZO FURANKED ISOCHINUCLIDEN DERIVATIVES AND METHOD FOR THE MANUFACTURE THEREOF
|
|
WO2013112163A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
EP2649989B1
(en)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Method for preparing a solid dispersion, solid dispersion obtained thereby and use thereof
|
|
US20130295170A1
(en)
|
2012-05-03 |
2013-11-07 |
Kydes Pharmaceuticals Llc |
Compositions for control of drug abuse
|
|
US20130295016A1
(en)
|
2012-05-07 |
2013-11-07 |
David J. Gerber |
Signatures of electroencephalographic oscillations
|
|
CN108498532B
(zh)
|
2012-05-09 |
2021-07-23 |
坎泰克斯制药股份有限公司 |
骨髓抑制的治疗
|
|
US8784835B2
(en)
|
2012-07-02 |
2014-07-22 |
Trent Austin |
Method for producing muscimol and/or reducing ibotenic acid from amanita tissue
|
|
WO2014008118A2
(en)
|
2012-07-02 |
2014-01-09 |
The General Hospital Corporation |
Method for concurrent treatment of pain and depression
|
|
EP2690102A1
(en)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bicyclic aza-amides for treatment of psychiatric disorders
|
|
WO2014028796A2
(en)
|
2012-08-17 |
2014-02-20 |
Smartek International Llc |
Preparation of desiccated liposomes for use in compressible delivery systems
|
|
AU2013305563B2
(en)
|
2012-08-24 |
2018-09-27 |
Integurx Therapeutics, Llc |
Chemical compositions and methods for enhancing transdermal delivery of therapeutic agents
|
|
US20140066881A1
(en)
|
2012-08-31 |
2014-03-06 |
Zoll Medical Corporation |
Cardiac resuscitation methods and kits
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
WO2014064703A1
(en)
|
2012-10-28 |
2014-05-01 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
EP2931291B1
(en)
|
2012-12-11 |
2021-10-20 |
The McLean Hospital Corporation |
Xenon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
US9783535B2
(en)
|
2012-12-20 |
2017-10-10 |
Demerx, Inc. |
Substituted noribogaine
|
|
WO2014117089A1
(en)
|
2013-01-25 |
2014-07-31 |
Case Western Reserve University |
Compositions and methods for the treatment of pervasive development disorders
|
|
WO2014130581A1
(en)
|
2013-02-20 |
2014-08-28 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
WO2014140925A2
(en)
|
2013-03-10 |
2014-09-18 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of topical disorders
|
|
WO2014153099A2
(en)
|
2013-03-14 |
2014-09-25 |
Pulmonary Analytics |
Method for using exhaled breath to determine the presence of drug
|
|
US20160030408A1
(en)
|
2013-03-15 |
2016-02-04 |
Bhl Patent Holdings Llc |
Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
|
|
CA2942638C
(en)
|
2013-03-15 |
2026-03-10 |
Demerx, Inc. |
Method for noribogaine treatment of addiction in patients on methadone
|
|
WO2014142938A1
(en)
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
|
KR20210113429A
(ko)
|
2013-03-15 |
2021-09-15 |
멜리어 파마슈티칼스 투, 엘엘씨. |
시드노카브 또는 이의 약학적으로 허용되는 염을 포함하는 약학적 조성물 및 수면 장애를 치료하는 방법
|
|
WO2014176556A1
(en)
|
2013-04-26 |
2014-10-30 |
Express Diagnostics International, Inc. |
Portable testing system for detecting selected drugs or compounds in non-controlled environments
|
|
WO2014186623A2
(en)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
MX2015016675A
(es)
|
2013-06-04 |
2016-07-15 |
Vyome Biosciences Pvt Ltd |
Particulas recubiertas y composiciones que comprenden las mismas.
|
|
WO2014197753A1
(en)
|
2013-06-08 |
2014-12-11 |
Sedogen, Llc |
Method of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia
|
|
EP2818177A1
(en)
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mechanism and drug targets for reducing cell edema (neuroprotection) and cytoplasmic excitability in astrocytes in normal and pathological states
|
|
CA2916973A1
(en)
|
2013-07-03 |
2015-01-08 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
CA2917159C
(en)
|
2013-07-08 |
2022-08-23 |
Auspex Pharmaceuticals, Inc. |
Dihydroxyphenyl neurotransmitter compounds, compositions and methods
|
|
JP6449871B2
(ja)
|
2013-07-12 |
2019-01-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エチレン−酢酸ビニルポリマーを含有する改変防止剤形
|
|
HK1223298A1
(zh)
*
|
2013-07-17 |
2017-07-28 |
阿拉伊姆药品公司 |
预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
US10098893B2
(en)
|
2013-10-03 |
2018-10-16 |
Northwestern University |
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
|
|
US9474481B2
(en)
*
|
2013-10-22 |
2016-10-25 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on electronic device usage
|
|
US9420970B2
(en)
|
2013-10-22 |
2016-08-23 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on mobile device usage
|
|
MX2016005477A
(es)
|
2013-10-31 |
2016-08-03 |
Cima Labs Inc |
Formas de dosificacion disuasivas del abuso.
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
TW201605856A
(zh)
|
2013-11-01 |
2016-02-16 |
艾尼納製藥公司 |
５－ＨＴｃ受體促效劑
|
|
CN103535561A
(zh)
|
2013-11-05 |
2014-01-29 |
杨剑 |
饲养大猪用的牧草饲料
|
|
CN103549133A
(zh)
|
2013-11-05 |
2014-02-05 |
杨剑 |
有机猪牧草饲料
|
|
CN103751943B
(zh)
|
2014-01-13 |
2020-10-13 |
湖北及安盾消防科技有限公司 |
一种含有含氮类有机化合物的灭火组合物
|
|
CN103773056B
(zh)
|
2014-01-24 |
2015-11-18 |
山东大学 |
高脆性透明类岩石材料试件制备方法
|
|
AU2014379612A1
(en)
|
2014-01-24 |
2016-08-11 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CA2978537C
(en)
|
2014-03-03 |
2023-10-24 |
Demerx, Inc. |
Therapeutic uses of ibogaine and related compounds
|
|
US20150258114A1
(en)
|
2014-03-13 |
2015-09-17 |
Demerx, Inc. |
Methods for acute and long-term treatment of substance abuse using ibogaine
|
|
US9878138B2
(en)
|
2014-06-03 |
2018-01-30 |
Pop Test Abuse Deterrent Technology Llc |
Drug device configured for wireless communication
|
|
US10202426B2
(en)
|
2014-07-30 |
2019-02-12 |
Genome Protection, Inc. |
Flagellin compositions and uses
|
|
US10231651B2
(en)
|
2014-09-25 |
2019-03-19 |
Bae Systems Information And Electronic Systems Integration Inc. |
Gait authentication system and method thereof
|
|
US10058253B2
(en)
|
2014-11-11 |
2018-08-28 |
Zenmark, Llc |
System, method, and article for heart rate variability monitoring
|
|
CA2979049A1
(en)
|
2015-03-10 |
2016-09-15 |
Eleusis Benefit Corporation, Pbc |
Lsd for the treatment of alzheimer's disease
|
|
AU2016237148A1
(en)
|
2015-03-24 |
2017-11-23 |
Kyowa Hakko Kirin Co., Ltd. |
Nucleic acid-containing lipid nanoparticles
|
|
US10254298B1
(en)
|
2015-03-25 |
2019-04-09 |
National Technology & Engineering Solutions Of Sandia, Llc |
Detection of metabolites for controlled substances
|
|
WO2016161138A1
(en)
*
|
2015-03-31 |
2016-10-06 |
Stamets Paul Edward |
Antiviral activity from medicinal mushrooms and their active constituents
|
|
DK3288946T3
(da)
|
2015-04-27 |
2019-11-25 |
Arena Pharm Inc |
5-ht2c-receptoragonister og sammensætninger og anvendelsesfremgangsmåder
|
|
EP3288636A4
(en)
|
2015-05-01 |
2019-01-16 |
Topitech Pharma Israel Ltd. |
COMPOSITIONS FOR THE TREATMENT OF EPISTAXIS
|
|
WO2016187277A1
(en)
|
2015-05-19 |
2016-11-24 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US20180147142A1
(en)
|
2015-05-19 |
2018-05-31 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US9737759B2
(en)
|
2015-07-17 |
2017-08-22 |
Genesant Technologies, Inc. |
Automatic application-based exercise tracking system and method
|
|
CA3002525A1
(en)
|
2015-07-31 |
2017-02-09 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
US9614734B1
(en)
|
2015-09-10 |
2017-04-04 |
Pearson Education, Inc. |
Mobile device session analyzer
|
|
JP2019523633A
(ja)
*
|
2016-04-29 |
2019-08-29 |
アライム ファーマシューティカルズ，インコーポレーテッド |
組織の損傷に関連した疾患及び障害を予防及び治療する組織保護ペプチド
|
|
US20210069170A1
(en)
|
2016-07-23 |
2021-03-11 |
Paul Edward Stamets |
Tryptamine compositions for enhancing neurite outgrowth
|
|
US20180021326A1
(en)
*
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
WO2018035477A1
(en)
|
2016-08-19 |
2018-02-22 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
US10596378B2
(en)
|
2016-10-18 |
2020-03-24 |
Joseph Rustick |
Method for treatment of depression using synaptic pathway training
|
|
US20180195455A1
(en)
|
2017-01-12 |
2018-07-12 |
GM Global Technology Operations LLC |
Engine combustion phasing control during transient state
|
|
NL2018190B1
(en)
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
EP3576755A4
(en)
|
2017-02-02 |
2020-12-02 |
McMaster University |
BICARBONATE AS A POTENTIALIZER OF ANTIMICROBIAL AGENTS
|
|
WO2018145219A1
(es)
|
2017-02-09 |
2018-08-16 |
Serani Mostazal Jorge |
Composición farmaceutica para la prevención y tratamiento de las adicciones a traves de un contracondicionamiento aversivo
|
|
CA3052974A1
(en)
|
2017-02-09 |
2018-08-16 |
CaaMTech, LLC |
Compositions and methods comprising a psilocybin derivative
|
|
CN108619214A
(zh)
|
2017-03-15 |
2018-10-09 |
王慎君 |
一种治疗肿瘤的药物
|
|
NZ757591A
(en)
|
2017-03-30 |
2026-03-27 |
Ojai Energetics Pbc |
Methods and compositions for enhancing health
|
|
AU2017408099A1
(en)
|
2017-04-07 |
2019-11-07 |
ACEA Therapeutics, Inc. |
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
|
|
US20200147038A1
(en)
|
2017-04-20 |
2020-05-14 |
Eleusis Benefit Corporation, Pbc |
Assessing and treating psychedelic-responsive subjects
|
|
US20190246591A1
(en)
|
2017-05-31 |
2019-08-15 |
Insectergy, Llc |
Insect and cannabis production systems and methods
|
|
US20180343812A1
(en)
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
EP3629899A4
(en)
|
2017-06-02 |
2021-04-21 |
Northwestern University |
Thin, soft, skin-mounted microfluidic networks for detection and analysis of targets of interest in sweat
|
|
CN107252080A
(zh)
|
2017-07-12 |
2017-10-17 |
沈建国 |
一种麻菇酱油的配方
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
EP3698260A4
(en)
|
2017-10-19 |
2021-08-04 |
Eleusis Health Solutions US, Inc. |
METHODS AND SYSTEMS FOR INCREASING THE SAFETY OF AWARENESS-ENHANCING DRUG THERAPIES
|
|
MA50786A
(fr)
|
2017-10-26 |
2022-04-27 |
Blumentech S L |
Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques
|
|
WO2019099745A1
(en)
|
2017-11-16 |
2019-05-23 |
CaaMTech, LLC |
Compositions comprising a psilocybin derivative and a cannabinoid
|
|
US10703325B2
(en)
|
2017-11-27 |
2020-07-07 |
Autoliv Asp, Inc. |
Multi-chambered side airbag assemblies
|
|
AU2018381331A1
(en)
|
2017-12-04 |
2020-07-23 |
Victoria Cogger |
Compositions and methods for modulating liver endothelial cell fenestrations
|
|
FI128750B
(en)
|
2017-12-21 |
2020-11-30 |
Helsingin Yliopisto |
Methods for determining the therapeutic effect of fast-acting antidepressants and related individual antidepressant therapy
|
|
US20190224277A1
(en)
|
2018-01-22 |
2019-07-25 |
CyPhi LLC |
Bio-mimetic formulation
|
|
WO2019161050A1
(en)
|
2018-02-18 |
2019-08-22 |
Akili Interactive Labs, Inc. |
Cognitive platform including computerized elements coupled with a therapy for mood disorder
|
|
CN120555529A
(zh)
|
2018-03-08 |
2025-08-29 |
指南针探路者有限公司 |
生产色胺的方法
|
|
FI129102B
(en)
|
2018-03-19 |
2021-07-15 |
Teknologian Tutkimuskeskus Vtt Oy |
Heterological production of psilosybin
|
|
AU2019262197B2
(en)
|
2018-05-04 |
2024-12-19 |
Perception Neuroscience, Inc. |
Methods of treating substance abuse
|
|
CA3148256A1
(en)
|
2018-06-21 |
2019-12-26 |
Robert John Petcavich |
Method of inducing dendritic and synaptic genesis in neurodegenerative chronic diseases
|
|
EP3829640A4
(en)
|
2018-08-01 |
2022-05-25 |
McMaster University |
Methods for inhibiting microbe growth
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
US11337937B2
(en)
*
|
2018-08-27 |
2022-05-24 |
ReJoy |
TARR receptor agonists for sexual dysfunction
|
|
WO2020053196A1
(en)
|
2018-09-10 |
2020-03-19 |
Universität Basel |
Method for the biocatalytic alkylation of a substrate
|
|
EP3906081A4
(en)
|
2019-01-04 |
2022-10-05 |
Apollo Neuroscience, Inc. |
SYSTEMS AND METHODS OF WAVE GENERATION FOR TRANSCUTANEOUS VIBRATIONS
|
|
AU2020215150B8
(en)
|
2019-01-30 |
2025-07-03 |
Diamond Therapeutics Inc. |
Methods and compositions comprising a 5HT receptor agonist for the treatment of psychological, cognitive, behavioral, and/or mood disorders
|
|
KR20220009954A
(ko)
|
2019-04-17 |
2022-01-25 |
컴퍼스 패쓰파인더 리미티드 |
신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
|
|
US20210015738A1
(en)
|
2019-07-17 |
2021-01-21 |
Concept Matrix Solutions |
Oral dissolvable film containing psychedelic compound
|
|
US11766445B2
(en)
|
2019-07-18 |
2023-09-26 |
Concept Matrix Solutions |
Oral soft gel capsule containing psychedelic compound
|
|
EP4009026B1
(en)
|
2020-12-02 |
2024-09-18 |
Volvo Truck Corporation |
An air-actuated vehicle system and a method of detecting leakage in an air-actuated vehicle system
|
|
EP4312995A1
(en)
|
2021-03-30 |
2024-02-07 |
COMPASS Pathfinder Limited |
Psilocybin compositions, methods of making and methods of using the same
|
|
MX2024005632A
(es)
|
2021-11-09 |
2024-07-29 |
Compass Pathfinder Ltd |
Tratamiento de la depresion resistente al tratamiento con psilocibina.
|